Latest Breaking News On - Taiwan headquartered united biopharma - Page 1 : comparemela.com

United BioPharma says the FDA has approved a clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases. 

Shugene lynnDrug administrationUs national institute of allergyTaiwan headquartered united biopharmaInfectious diseasesOpen label phaseOptimized background antiretroviral therapyMulti drug resistant